Cochrane Abstracts
Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Short‐term Treatment With Proton Pump Inhibitors, H2‐receptor Antagonists and Prokinetics for Gastro‐oesophageal Reflux Disease‐like Symptoms and Endoscopy Negative Reflux Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short_term_treatment_with_proton_pump_inhibitors__H2_receptor_antagonists_and_prokinetics_for_gastro_oesophageal_reflux_disease_like_symptoms_and_endoscopy_negative_reflux_disease:_Cochrane_systematic_review.
Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short_term_treatment_with_proton_pump_inhibitors__H2_receptor_antagonists_and_prokinetics_for_gastro_oesophageal_reflux_disease_like_symptoms_and_endoscopy_negative_reflux_disease:_Cochrane_systematic_review. Accessed January 19, 2026.
Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short_term_treatment_with_proton_pump_inhibitors__H2_receptor_antagonists_and_prokinetics_for_gastro_oesophageal_reflux_disease_like_symptoms_and_endoscopy_negative_reflux_disease:_Cochrane_systematic_review
Short‐term Treatment With Proton Pump Inhibitors, H2‐receptor Antagonists and Prokinetics for Gastro‐oesophageal Reflux Disease‐like Symptoms and Endoscopy Negative Reflux Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short_term_treatment_with_proton_pump_inhibitors__H2_receptor_antagonists_and_prokinetics_for_gastro_oesophageal_reflux_disease_like_symptoms_and_endoscopy_negative_reflux_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease
ID - 435254
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short_term_treatment_with_proton_pump_inhibitors__H2_receptor_antagonists_and_prokinetics_for_gastro_oesophageal_reflux_disease_like_symptoms_and_endoscopy_negative_reflux_disease:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
